303,900€
-0,77%
Echtzeit-Aktienkurs West Pharmaceutical Services
Bid:
Ask:
Echtzeit-Chart der West Pharmaceutical Services Aktie
Börsenkurse West Pharmaceutical Services
| Börse Stuttgart | - | - | - | - | 303,400€ | 0,33% |
| Börse Frankfurt | - | - | - | - | 304,050€ | 3,77% |
| gettex | - | - | - | - | 303,950€ | -0,77% |
| Echtzeit Euro | - | - | - | - | 304,150€ | 1,21% |
| Lang & Schwarz | - | - | - | - | 303,900€ | -0,77% |
| Echtzeit USD | - | - | - | - | 317,011$ | -1,21% |
| USA | - | - | - | - | 316,590$ | 1,58% |
| Tradegate | - | - | - | - | 303,950€ | -0,70% |
| New York | - | - | - | - | 316,170$ | -1,47% |
Fundamentaldaten der West Pharmaceutical Services Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [USD] | 2,95 Mrd. | 698,00 Mio. | 593,40 Mio. | - | 0,26% | - | 7,57 |
| 2022 [USD] | 2,89 Mrd. | 679,90 Mio. | 585,90 Mio. | - | 0,24% | - | 7,80 |
| 2021 [USD] | 2,83 Mrd. | 748,90 Mio. | 661,80 Mio. | - | 0,23% | - | 7,97 |
| 2020 [USD] | 2,15 Mrd. | 401,30 Mio. | 346,20 Mio. | - | 0,22% | - | 10,48 |
| 2019 [USD] | 1,84 Mrd. | 291,80 Mio. | 241,70 Mio. | - | 0,20% | - | 12,21 |
| 2018 [USD] | 1,72 Mrd. | 240,70 Mio. | 206,90 Mio. | - | 0,19% | - | 13,11 |
| 2017 [USD] | 1,60 Mrd. | 222,40 Mio. | 150,70 Mio. | - | 0,18% | - | 14,03 |
| 2016 [USD] | 1,51 Mrd. | 189,80 Mio. | 143,60 Mio. | - | 0,16% | - | 14,72 |
| 2015 [USD] | 1,40 Mrd. | 116,10 Mio. | 95,60 Mio. | - | 0,15% | - | 15,72 |
| 2014 [USD] | 1,42 Mrd. | 169,00 Mio. | 127,10 Mio. | - | 0,14% | - | 15,24 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der West Pharmaceutical Services Aktie
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.